Marvel Biosciences Secures $300,000 Grant to Advance Groundbreaking Alzheimer's Research
Newsfile· 2024-11-21 20:00
Calgary, Alberta--(Newsfile Corp. - November 21, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), today is pleased to announce it has been awarded the Alberta Innovates AICE Validates grant, securing $300,000 in funding to support the preclinical validation of MB204 as a treatment for Alzheimer's disease. This funding represents a significant step forward for Marvel, providing the resources and ...
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies
GlobeNewswire News Room· 2024-11-21 20:00
New York, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Grapevine, at the forefront of healthcare supply chain innovation, announces that The Oncology Institute (TOI) has achieved over $1.7 million in medical supply savings year to date. With monthly savings climbing to an unprecedented 61% in July 2024, this milestone underscores the profound impact of Grapevine’s digital supply chain solutions on healthcare, unlocking substantial cost-saving potential for medical facilities. Inefficiencies in supply chains have ...
TOP EXPLORATION TEAM JOINS LUCA AS MAJOR DRILLING PROGRAMS GET UNDERWAY
Prnewswire· 2024-11-21 20:00
VANCOUVER, BC, Nov. 21, 2024 /PRNewswire/ - Luca Mining Corp. ("Luca" or the "Company") (TSXV: LUCA) (OTCQX: LUCMF) (Frankfurt: Z68) is pleased to announce the hiring of a highly experienced geological team to execute the Company's ambitious exploration strategy at both Tahuehueto and Campo Morado.The primary objective of the exploration strategy is to create significant value by focusing on three key goals: Identify additional high-grade, near-mine mineralization that can be quickly added to the mine plans ...
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit
GlobeNewswire News Room· 2024-11-21 20:00
FREDERICK, Md., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that updated efficacy and safety data from the Phase 2b trial of Descartes-08 in patients with generalized myasthenia gravis will be presented at the 2nd Annual Cell Therapy for Autoimmune Disease Summit, being held December 2-4, 2024 in Philadelphia. Details of the presentation are as follo ...
Nvidia Earnings: This Stock Is In Danger Of Hitting A Wall (Rating Downgrade)
Seeking Alpha· 2024-11-21 20:00
Nvidia (NASDAQ: NVDA ) reported earnings after the close Wednesday as the market waited with bated breath to see how the world's most valuable company and the driver of the AI wave would perform. All inTo follow me click the "Follow" button! (Easy right?) Hi there, thanks for coming to my profile page! My name is Kumquat Research (but you can call me Jeremy) and I've been writing for Seeking Alpha on and off for going on ten years now, beginning with my inaugural published piece during my first year of coll ...
LLCP Announces the Successful Close of $575 Million Multi-Asset Continuation Fund
Prnewswire· 2024-11-21 20:00
BEVERLY HILLS, Calif., Nov. 21, 2024 /PRNewswire/ -- Levine Leichtman Capital Partners ("LLCP") is pleased to announce the closing of a $575 million multi-asset continuation fund transaction. LLCP LMM Acquisition Fund, L.P. was formed to acquire interests in three portfolio companies – Blue Ridge Associates, Milton Industries and Resolution Economics – from LLCP Lower Middle Market Fund, L.P. ("LMM II"). Hamilton Lane (Nasdaq: HLNE) acted as lead investor and was supported by a diverse syndicate of institut ...
Unicycive Therapeutics to Participate in Two Upcoming Investor Conferences Including a Fireside Chat at the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire News Room· 2024-11-21 20:00
LOS ALTOS, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer will participate in two upcoming investment conferences in December. Event:Noble Capital Markets 20th Annual Emerging Growth Equity ConferenceType:Corporate PresentationDate/Time:Tuesday, December 3, 2024 at 3:00 p.m. ETLoca ...
Instacart Becomes the First Online Grocery Platform to Launch a SNAP Eligibility Screener to Educate Consumers and Streamline Access to Benefits Nationwide
Prnewswire· 2024-11-21 20:00
New tool designed to help reduce barriers to access, expands the SNAP resources available on InstacartSAN FRANCISCO, Nov. 21, 2024 /PRNewswire/ -- Instacart (NASDAQ: CART), the leading online grocery delivery platform in North America, today announced a new Supplemental Nutrition Access Program (SNAP) eligibility screener available on Instacart's EBT SNAP information page. The new tool, powered by Advocatia Solutions, Inc., lets people nationwide quickly and anonymously check whether they may be eligible fo ...
Arthur J. Gallagher & Co. Acquires THB Chile
Prnewswire· 2024-11-21 20:00
ROLLING MEADOWS, Ill., Nov. 21, 2024 /PRNewswire/ -- Arthur J. Gallagher & Co. today announced the acquisition of Santiago, Chile-based THB Chile. Terms of the transaction were not disclosed.THB Chile is a retail insurance broker providing property/casualty, life and health benefits, and reinsurance services to clients throughout Chile. The THB Chile team will operate under the direction of Lionel Soffia, head of Gallagher's retail insurance and reinsurance brokerage operations in Chile and Latin America."T ...
Wix Q3: Surpassing 'Rule Of 40' Ahead Of Schedule
Seeking Alpha· 2024-11-21 20:00
I recently joined The REIT Forum and if you are looking for more investment ideas like this one, get them exclusively at The REIT Forum with access to our subscriber only portfolios.I last wrote about Wix (NASDAQ: WIX ) in August, where I reiterated my “buy” rating with a price target of $200. Since then, the stock has climbed close to 30% and, with the latestAmrita runs a boutique family office fund in beautiful Vancouver, where she leads the investment strategy for the family fund. The fund's objective is ...